Clinical Trial Update: Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury [Phase 2]

View source ↗

Summary

Phase 2 safety study of ornithine phenylacetate for acute liver failure/severe acute liver injury has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure
• Liver Injury

Drugs mentioned

• Ornithine phenylacetate (ornithine phenylacetate)

Snippet

Sponsor: William Lee | Conditions: Acute Liver Failure, Acute Liver Injury | Phase 2 | Status: COMPLETED | Results posted: 2018-09-20